Cardinal Health (CAH) shares climb as profits boosted by pharmaceutical and medical units
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
Cardinal Health (CAH) Tops Q1 EPS by 32c; Raises Outlook
November 3, 2023 6:57 AM EDTCardinal Health (NYSE: CAH) reported Q1 EPS of $1.73, $0.32 better than the analyst estimate of $1.41. Revenue for the quarter came in at $54.8 billion versus the consensus estimate of $54.76 billion.
GUIDANCE:
Cardinal Health sees FY2024 EPS of $6.75-$7.00, versus prior of $6.50-$67.5... More
